Familial nonmedullary thyroid carcinoma-clinical relevance and prognosis. A European multicenter study : ESES Vienna presentation

Langenbeck's Archives of Surgery

Volumn 395, Issue 7, 2010, Pages 851-858

  Hillenbrand, Andreas ^a   Varhaug, Jan Erik ^b   Brauckhoff, Michael ^b   Pandev, Rumen ^c   Haufe, Sabine ^d   Dotzenrath, Cornelia ^e   Köberle, Roswitha ^f   Hoffmann, Rainer ^g   Klein, Günther ^h   Kadmon, Martina ^d   Negele, Thomas ⁱ   Hagieva, Tatjana ^c   Henne Bruns, Doris ^a   Luster, Markus ^a   Weber, Theresia ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e HELIOS KLINIKUM WUPPERTAL   (Germany)

^f Landeskrankenhaus Feldkirch   (Austria)

^g KLINIK HIRSLANDEN   (Switzerland)

^h Landesklinikum Wiener Neustadt ^*  (Austria)

ⁱ Martha und Maria Helfen Krankenhaus Munchen   (Germany)

Author keywords

Familial nonmedullary thyroid carcinoma; FNMTC; Lymph node metastases; Papillary thyroid carcinoma; Prognosis

Indexed keywords

RADIOACTIVE IODINE; THYROGLOBULIN;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; BONE METASTASIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CAUSE OF DEATH; CERVICAL LYMPH NODE; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FAMILIAL CANCER; FAMILIAL NONMEDULLARY THYROID CARCINOMA; FAMILY STUDY; FEMALE; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; LUNG METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MEDICAL SOCIETY; METASTASIS; MULTIPLE CANCER; OVERALL SURVIVAL; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; RADIOIODINE ABLATION; SEX RATIO; SUBTOTAL THYROIDECTOMY; SURGEON; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TUMOR VASCULARIZATION; TUMOR VOLUME; ULTRASOUND;

ADENOCARCINOMA, FOLLICULAR; ADENOCARCINOMA, PAPILLARY; ADOLESCENT; ADULT; AGED; BIOPSY, NEEDLE; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PEDIGREE; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78149410114     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-010-0696-0     Document Type: Article

References (30)

1. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer DS Cooper GM Doherty BR Haugen RT Kloos SL Lee SJ Mandel EL Mazzaferri B McIver F Pacini M Schlumberger SI Sherman DL Steward RM Tuttle 2009 Revised American Thyroid Association management of thyroid nodules and differentiated thyroid cancer Thyroid 19 1167 1214 10.1089/thy.2009.0110 19860577
2. L Davies HG Welch 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002 JAMA 295 2164 2167 1:CAS:528:DC%2BD28XksV2gtLg%3D 10.1001/jama.295.18.2164 16684987
3. KC Loh 1997 Familial nonmedullary thyroid carcinoma: a meta-review of case series Thyroid 7 107 113 1:STN:280:DyaK2s3ktFajtQ%3D%3D 10.1089/thy.1997.7.107 9086578
4. RS Sippel NR Caron OH Clark 2007 An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up World J Surg 31 924 933 10.1007/s00268-006-0847-1 17429563 (Pubitemid 46716780)
5. DW Robinson TG Orr 1955 Carcinoma of the thyroid and other diseases of the thyroid in identical twins AMA Arch Surg 70 923 928 1:STN:280: DyaG2M%2Fnslamtg%3D%3D 14375516
6. SS Stoffer DL Van Dyke JV Bach W Szpunar L Weiss 1986 Familial papillary carcinoma of the thyroid Am J Med Genet 25 775 782 1:STN:280: DyaL2s%2FntlGguw%3D%3D 10.1002/ajmg.1320250415 3789026 (Pubitemid 17191443)
7. K Hemminki C Dong 2000 Familial relationships in thyroid cancer by histo-pathological type Int J Cancer 85 201 205 1:STN:280: DC%2BD3c%2FpsVOqtQ%3D%3D 10629078
8. Y Ito M Fukushima T Yabuta H Inoue T Uruno M Kihara T Higashiyama Y Takamura A Miya K Kobayashi F Matsuzuka A Miyauchi 2008 Prevalence and prognosis of familial follicular thyroid carcinoma Endocr J 55 847 852 10.1507/endocrj.K08E-057 18506092
9. V Zivaljevic I Paunovic A Diklic K Krgovic N Kalezic M Kazic S Tatic D Savic D Stojanovic R Perunovic 2008 The incidence of familial nonmedullary thyroid cancer in a large case series Acta Chir Belg 108 328 332 1:STN:280:DC%2BD1cris1antg%3D%3D 18710108
10. S Bevan T Pal CR Greenberg H Green J Wixey G Bignell SA Narod WD Foulkes MR Stratton RS Houlston 2001 A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1 J Clin Endocrinol Metab 86 8 3701 3704 1:CAS:528:DC%2BD3MXlvFektLg%3D 10.1210/jc.86.8.3701 11502798 (Pubitemid 32755963)
11. O Alsanea N Wada K Ain M Wong K Taylor IPH Treseler WHU PA N Freimer AE Siperstein QY Duh H Takami OH Clark 2000 Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series Surgery 128 1043 1050 1:STN:280:DC%2BD3M%2FnsFehtA%3D%3D 10.1067/msy.2000.110848 11114641
12. Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM Classification of Malignant Tumours (Uicc International Union Against Cancer). Blackwell, London
13. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK (eds). SEER Cancer Statistics Review, 1975-2007, National Cancer Institute. Bethesda, MD, http://seer.cancer. gov/csr/1975-2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010
14. NR Caron OH Clark 2004 Well differenciated thyroid cancer Scand J Surg 93 261 271 1:STN:280:DC%2BD2M%2FjtFGntw%3D%3D 15658666
15. A Machens HJ Holzhausen H Dralle 2005 The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma Cancer 103 2269 2273 10.1002/cncr.21055 15856429 (Pubitemid 40686570)
16. S Uchino S Noguchi H Kawamoto H Yamashita S Watanabe H Yamashita S Shuto 2002 Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population World J Surg 26 897 902 10.1007/s00268-002-6615-y 11965446 (Pubitemid 36920283)
17. RF Grossman SH Tu QY Duh AE Siperstein F Novosolov OH Clark 1995 Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment Arch Surg 130 892 897 1:STN:280:DyaK2MzlvVKqtQ%3D%3D 7632152
18. G Lupoli G Vitale M Caraglia MR Fittipaldi A Abbruzzese P Tagliaferri AR Bianco 1999 Familial papillary thyroid microcarcinoma: a new clinical entity Lancet 353 637 639 1:STN:280:DyaK1M7ltlCjsw%3D%3D 10.1016/S0140-6736(98)08004-0 10030330 (Pubitemid 29087985)
19. F Triponez M Wong C Sturgeon N Caron DG Ginzinger MR Segal E Kebebew QY Duh OH Clark 2006 Does familial non-medullary thyroid cancer adversely affect survival? World J Surg 30 787 793 10.1007/s00268-005-0398-x 16479341 (Pubitemid 43724107)
20. Edge S, Byrad DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual. Springer, New York, pp 87-96
21. EL Maxwell FT Hall JL Freeman 2004 Familial non-medullary thyroid cancer: a matched-case control study Laryngoscope 114 12 2182 2186 10.1097/01.mlg. 0000149454.91005.65 15564841 (Pubitemid 39602485)
22. F Leprat F Bonichon M Guyot H Trouette M Trojani V Vergnot M Longy G Belleannée A de Mascarel P Roger 1999 Familial non-medullary thyroid carcinoma: pathology review in 27 affected cases from 13 French families Clin Endocrinol 50 589 594 1:STN:280:DyaK1MvgsFWjtw%3D%3D 10.1046/j.1365-2265.1999. 00687.x (Pubitemid 29236335)
23. C Sturgeon OH Clark 2005 Familial nonmedullary thyroid cancer Thyroid 15 588 593 10.1089/thy.2005.15.588 16029126 (Pubitemid 40993733)
24. M Capezzone S Marchisotta S Cantara G Busonero L Brilli K Pazaitou-Panayiotou AF Carli G Caruso P Toti S Capitani A Pammolli F Pacini 2008 Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity Endocr Relat Cancer 15 1075 1081 1:STN:280:DC%2BD1M%2Fos1yqtA%3D%3D 10.1677/ERC-08-0080 18832444
25. Larsen K, Petersen J, Bernstein I, Nilbert M (2009) A parametric model for analyzing anticipation in genetically predisposed families. Stat Appl Genet Mol Biol 8:Article26
26. ND Charkes 1998 On the prevalence of familial nonmedullary thyroid cancer Thyroid 8 857 858 1:STN:280:DyaK1cvkvFWrtQ%3D%3D 10.1089/thy.1998.8.857 9777757
27. ND Charkes 2006 On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds Thyroid 16 181 186 10.1089/thy.2006.16.181 16613533
28. K Hemminki C Eng B Chen 2005 Familial risks for nonmedullary thyroid cancer J Clin Endocrinol Metab 90 5747 5753 1:CAS:528:DC%2BD2MXhtFWjt7vO 10.1210/jc.2005-0935 16030170 (Pubitemid 41415486)
29. T Pal FD Vogl PO Chappuis R Tsang J Brierley H Renard K Sanders T Kantemiroff S Bagha DE Goldgar SA Narod WD Foulkes 2001 Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study J Clin Endocrinol Metab 86 5307 5312 1:CAS:528:DC%2BD3MXos1KqsLc%3D 10.1210/jc.86.11.5307 11701697 (Pubitemid 33070252)
30. L Khara A Silverman C Bethel C D'Cruz X Sun 2010 Thyroid papillary carcinoma in a 3-year-old American boy with a family history of thyroid cancer: a case report and literature review J Pediatr Hematol Oncol 32 e118 e121 10.1097/MPH.0b013e3181c97c57 20216232